Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1549230 NEW YORK, NY

Position in XENE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,724,457
+$14,125,235 QoQ
Shares Held
270,412
+657.9% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Derivatives in XENE

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$1,600,074
PutShares
35,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $541,089,850 across 142 Biotechnology names. XENE ranks #8 (2.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 XENE
Xenon Pharmaceuticals Inc.
This page
270,412 $15,724,457

All Filings in XENE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,724,457 270,412
2025-12-31 $1,599,222 35,681
2025-12-31 $1,600,074 35,700
2025-09-30 $1,158,688 28,859
2024-12-31 $681,884 17,395
2024-09-30 $1,186,808 30,145
2024-06-30 $1,175,353 30,145
2024-03-31 $1,307,041 30,361
2023-12-31 $1,854,191 40,256
2023-06-30 $384,345 9,983
2023-03-31 $423,216 11,825
2022-12-31 $466,259 11,825
2022-09-30 $426,882 11,825
2022-06-30 $800,228 26,306
2022-03-31 $743,645 24,326
2021-12-31 $574,066 18,376
2021-09-30 $349,912 22,900
2021-09-30 $784,230 51,324
2021-09-30 $835,816 54,700
2021-06-30 $377,986 20,300
2021-06-30 $1,782,995 95,757
2021-03-31 $1,625,606 90,816
2020-12-31 $653,849 42,513
2020-09-30 $404,254 36,518
2020-06-30 $560,349 44,685
2020-03-31 $736,975 64,989